Entry inhibitors show promise as drugs with new MOA for treatment of HBV and HDV infection
Links shared publicly online about this topic.
- 394total visits
Entry inhibitors show promise as drugs with new MOA for treatment of HBV and HDV infection
View full resource at sciencedaily.com
Tags: Liver Condition, Hepatitis, Hepatitis B, Hepatitis D, Infection, Drug
Most Recently Shared on April 2, 2011 at 9:08 pm By:
Entry inhibitors show promise as drugs with new MOA for treatment of HBV and HDV infection: Promising new viral ... http://bit.ly/gB7rig
Entry Inhibitors Show Promise As Drugs With New MOA For Treatment Of HBV And HDV Infection - QualityPoint Technologies
qualitypointtech.net — “Promising new viral hepatitis data presented at the International Liver CongressTM show that entry inhibitors - a new mechanism of action for drugs to treat viral hepatitis - could provide the first new hepatitis B and hepatitis D treatments for many years.1,2 Most current approved therapies directly target viral replication (e.g. nucleotide/side analogues), and can lead to the development of viral resistance or viral rebound after the end of treatment...” View full resource at qualitypointtech.net
Most Recently Shared on April 3, 2011 at 3:35 pm By:
Entry Inhibitors Show Promise As Drugs With New MOA For Treatment Of HBV And HDV Infection: Promising new viral he... http://bit.ly/eCZmB3
Entry Inhibitors Show Promise As Drugs With New MOA For Treatment Of HBV And HDV Infection
medicalnewstoday.com — “Promising new viral hepatitis data presented at the International Liver CongressTM show that entry inhibitors - a new mechanism of action for drugs to treat viral hepatitis - could provide the fir” View full resource at medicalnewstoday.com
Most Recently Shared on April 3, 2011 at 3:05 pm By:
Entry Inhibitors Show Promise As Drugs With New MOA For Treatment Of HBV And HDV Infection http://mnt.to/3T67 #liver #hepatitis
Advertisement
